Imaging in multiple sclerosis
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
ultiple sclerosis (MS) is a common central nervous system (CNS) disease characterised pathologically by the development of multifocal inflammatory demyelinating white matter lesions.Magnetic resonance imaging (MRI) is the gold standard imaging technique for the identification of demyelinating lesions which can be used to support a clinical diagnosis of MS, and MS can now be diagnosed in some patients after a clinically isolated syndrome (CIS) using new MRI diagnostic criteria.Clinical trials of disease modifying treatments include MRI outcome measures of disease activity.The use of MR techniques to study the evolution of MS pathology in vivo is an important tool for obtaining better insights into pathophysiological mechanisms underlying the clinical course.This article will concentrate on the practical application of MRI in the management of MS. MRI CONTRAST HELPS TO IDENTIFY MS PATHOLOGYc MR images are said to have contrast if there are differing areas of signal intensity.The contrast can be controlled to a certain extent by the parameters used and can produce images which contain differing levels of contrast depending on tissue content.For example, fat and water produce different image contrast.Images can be weighted towards particular contrast mechanisms.In T1 weighted images, fat is bright and cerebrospinal fluid (CSF) is dark; with T2 weighting, fat is dark and CSF is bright.Proton density (PD) weighting produces image contrast on the basis of the PD of the tissue.Such weighting of images has been exploited to identify inflammatory demyelinating lesions at different stages in their evolution. 1T2 and PD weighted imaging T2 weighted imaging identifies MS lesions as high signal foci against the low signal background of white matter.However, periventricular lesions are often indistinguishable from the adjacent CSF which is also of high signal with T2 weighting.Contrast from the lesion can be improved here by using PD weighting because of the lower CSF signal with this sequence.Fortunately, T2 and PD weighted images can be acquired together in a single spin-echo sequence providing complimentary information (fig 1). Fluid attenuated inversion recovery (FLAIR) sequenceThe problem of identifying lesions in the periventricular region, which is a common site for MS lesions, can also be addressed by suppressing the signal from CSF yet maintaining heavy T2 weighting using a fluid attenuated inversion recovery (FLAIR) sequence (fig 1).This sequence is also superior at detecting cortical/juxtacortical lesions.FLAIR is therefore a commonly used MR sequence on clinical scanners when MS has been raised as a possible clinical diagnosis.The only drawback is inferior quality lesion detection in the posterior fossa and spinal cord where PD and T2 weighting are preferred.T1 weighted imaging without contrast Some high signal lesions on T2 weighted imaging will also be visible on T1 weighted images as areas of low signal compared to the normal white matter and are commonly known as ''black holes'' (fig 2).Such lesions when newly formed will either disappear with time, when it is thought they are caused by reversible oedema or demyelination, or persist as chronic black holes, when it is thought they are caused by permanent axonal loss. T1 weighted imaging with gadolinium enhancementA gadolinium chelate administered intravenously five minutes before T1 weighted imaging detects blood-brain barrier breakdown in association with active inflammation.New lesions appear enhanced (fig 1) and usually persist for a month on average, making them a useful marker for monitoring disease activity.Such lesions play an important role in indicating dissemination in time within the new diagnostic criteria.Triple dose gadolinium or combination with iii11 www.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
Lennon, V. A., Wingerchuk, D. M., Kryzer, T. J., Pittock, S. J., Lucchinetti, C. F., Fujihara, K., Nakashima, I., & Weinshenker, B. G. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17551-x · Cited by 3,239
Barkhof, F. (1997) · Brain · doi:10.1093/brain/120.11.2059 · Cited by 1,251
Miller, D., Barkhof, F., Montalban, X., Thompson, A., & Filippi, M. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70071-5 · Cited by 594
Self-citation
Cited by
CLINICAL VIRAL INFECTIONS AND MULTIPLE SCLEROSIS
SIBLEY, W. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92801-6 · Cited by 594
Advances in multimodal data fusion in neuroimaging: Overview, challenges, and novel orientation
Zhang, Y.-D., Dong, Z., Wang, S.-H., Yu, X., Yao, X., Zhou, Q., Hu, H., Li, M., Jiménez-Mesa, C., Ramirez, J., et al. (2020) · Information Fusion · doi:10.1016/j.inffus.2020.07.006 · Cited by 453
Guglielmetti, C., Le Blon, D., Santermans, E., Salas-Perdomo, A., Daans, J., De Vocht, N., Shah, D., Hoornaert, C., Praet, J., Peerlings, J., et al. (2016) · Glia · doi:10.1002/glia.23053 · Cited by 76
Snow, N. J., Wadden, K. P., Chaves, A. R., & Ploughman, M. (2019) · Neural Plasticity · doi:10.1155/2019/6430596 · Cited by 56
Cervical spinal cord susceptibility-weighted MRI at 7T: application to multiple sclerosis
Clarke, M. A., Witt, A. A., Robison, R. K., Fleishman, S., Combes, A. J. E., Houston, D., Prock, L. E., Sweeney, G., O'Grady, K. P., McKnight, C. D., et al. (2023) · NeuroImage · doi:10.1016/j.neuroimage.2023.120460 · Cited by 21
“With almost 9 in 10 MS patients having spinal lesions (Moccia et al., 2019) and cord lesions being specific for demyelinating disease (Trip and Miller 2005), their presence can be used to support an MS diagnosis when brain MRI findings are inconclusive (Filippi et al., 2019) and thus lead to…”
Metadata
- Authors
- Trip, S. A.
- Venue
- Journal of Neurology, Neurosurgery & Psychiatry
- Publisher
- BMJ
- Published
- 2005-09-01
- Volume
- 76
- Issue
- suppl_3
- Pages
- iii11-iii18
- ISSN
- 0022-3050 (ISSN-L)
- OpenAlex
- W2127158158
- Cited by
- 77
- References
- 3
- FWCI
- 0.20
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Imaging in multiple sclerosis. https://app.cochat.ai/papers/10.1136/jnnp.2005.073213
- The paper
- Trip, S. A. (2005). Imaging in multiple sclerosis. Journal of Neurology, Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.2005.073213
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.